Pressure BioSciences, Inc. · OTC:PBIO
Pressure BioSciences — Investor Presentation (July 2014)
25 slides from Pressure BioSciences's investor presentation, Jul 15, 2014
Slide 1: Pressure BioSciences, Inc. Investor Presentation
Investor Presentation Pressure BioSciences, Inc. (OTCQB: PBIO) Discovery Starts with Sample Preparation™ Investor Presentation July 10, 2014 Richard T. Schumacher PBI President, CEO, Board Member
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation may contain forward looking statements that reflect management's current views and opinions as to the status of the Company's products, technology and other future events and operations. These statements are neither a promise nor guarantee, but involve ri
Slide 3: Company Overview
Company Overview + OTCQB: PBIO + Nine (9) FT Employees; Strong Mgmt Team and Board of Directors + 24 Patents: Pressure Cycling Technology (PCT) Platform + ~32M Common Shares/CS Equivalents OS (Float ~12M) + Market Cap (fully diluted): $10.5 Million + Development and Sale of PCT-based Products (Instr
Slide 4: Experienced Senior Management & Board
Experienced Senior Management & Board Management + Mr. Richard T. Schumacher, President & CEO Boston Biomedica (CEO, Founder); Panacos Pharma (President, Co-founder); Trinity Biotech (Founding Group); CBR Labs (Gen’ | Mgr) - Harvard Medical School + Dr. Edmund Y. Ting, Senior Vice President of Engin
Slide 5: What is a Biomarker?
What is a Biomarke: Molecules (e.g., genes, proteins, lipids) found in tissue (e.g., cells) or body fluids (e.g., blood) that correlate — directly or indirectly — with the presence or absence, the progression or recurrence, and the effects of treatment on a disease or a disorder. Identify Disease Bi
Slide 6: Estimated Market: Biomarker Discovery
'stimated Market: Biomarker Discovery R&D Services Biomarker Discovery Pharmaceuti- Biotechnology 3 R&D “Biomarker Validation Sopice eags Sees. Academic and WW Biomarker Market Est. to Reach $25.79B, by 2016 - 2012 ASDReports Diagnostics Near Patent Care S Emergency Room tpoe Diagnostics b meats or
Slide 7: Value Proposition: PCT-based biological sample preparation
Value Proposition: PCT-based biological sample preparation + Analysis of DNA, RNA, Proteins, & Lipids (“biomolecules”) is Crucial to the Discovery of New Biomarkers + The Quality of Biomolecule Analysis Depends Significantly on the Quality of the Preparation of the Sample to be Analyzed + Biological
Slide 8: Sample Preparation
Sample Preparation Sample preparation is a term that refers to a wide range of activities that precede virtually all forms of scientific analysis. Sample preparation is often complex, time- consuming, and one of the most error-prone steps of scientific research. It is none-the-less a ubiquitous labo
Slide 9: Necessary Sample Preparation for Cell Lysis
ary Sample Preparation for Cell Lysis
Slide 10: Tools for Discovery
ols for Discovery 500,000 Scientists in 80,000 Biological Research Labs WW Assortment of Analytical Instruments Used in the Discovery Process, e.g., + HPLC (est. of over 230,000 systems currently in use) + Mass Spectrometers (est. of over 16,000 MS labs WW) + DNA Sequencers, Real Time PCR + Electrop
Slide 11: Sample Input Quality = Sample Result Quality
Sample Input Quality = Sample Result Quality Scientific research can be broken down to three key elements: sample preparation, analysis, & data reduction/interpretation PBI “Discovery Starts with Sample Preparation” "
Slide 12: Biomarker/Forensics Sample Prep Market: Estimated Size
Biomarker/Forensics Sample Prep Market: Estimated Size + Genomics (DNA/RNA) Market to Reach $7.1B in 2015 > + Next Generation Sequencing (DNA) Market to Reach $2.7B in 2017¢ + Mass Spectrometry Market (Proteins/Lipids) at $2.7B in 2011 and Predicted to Increase at a CAGR of 7.83 Percent for 2011-201
Slide 13: Competitive Landscape
Competitive Landscape Nearly All Competitive Methods Involve Mechanical Disruption Mortar & Pestle Dounce homogenizer (glass on glass) Potter-Elvenhjem homogenizer (Teflon on glass) Enzymatic Digestion Polytron shearing homogenizers Blenders Bead Beating Sonication Repeated Freeze/Thaw cycles French
Slide 14: PCT Sample Preparation System
PCT Sample Preparation System — Em Barocycler™ NEP2320 Barocycler™ NEP3229 PCT-dependent Kits PBI MicroTubes 4
Slide 15: Selected Marquee Customers (40 of 150)
Selected Marquee Customers (40 of 150) Amgen Biogen Lilly Novartis Monsanto BM Squibb Merck Centocor Takeda Pharmaceuticals Momenta Pharmaceuticals US Army FBI Food and Drug Administration US Department of Agriculture National Institutes of Health Armed Forces Inst. of Pathology Centers for Disease
Slide 16: PCT Focus Area: Biomarker Discovery & Forensics
PCT Focus Area: Biomarker Discovery & Forensics Biomarker Discovery: Cancer, Heart Disease, Stroke, Inf. Diseases, Etc. Dr. Andreas Huhmer — Thermo Fisher Scientific advantages of speed and quality using PCT in mass spec workflow Dr. Michael Alterman — Tumor Vaccines and Biotechnology Branch, CBER,
Slide 17: Professor Wayne Hubbell - UCLA
Professor Wayne Hubbell - UCLA Distinguished Professor of Chemistry & Biochemistry, and Jules Stein Professor at UCLA "Protein flexibility is the new frontier in understanding protein function and regulation. The study of proteins under pressure has great ability to reveal salient features of protei
Slide 18: PCT Focus Area: Biomarker Discovery & Forensics
PCT Focus Area: Biomarker Discovery & Forensics Forensics Dr. Bruce Budowle, Health Science Center, University of North Texas improved detection of DNA in forensic samples using PCT Dr. Bruce McCord, Florida International University improved processing of forensic (rape kit) samples using PCT Dr. Pa
Slide 19: Dr. Henry C. Lee
Dr. Henry C. Lee Professor of Forensic Science and founder of the Forensic Science Program at the University of New Haven; founder of the HC Lee Institute of Forensic Sciences; and former Commissioner of Public Safety for the State of Connecticut. “We are excited about this opportunity to collaborat
Slide 20: The Problem
The Problem Automated liquid handling helps ensure accuracy and reproducibility, eliminates repetitive tasks, and frees personnel for other activities. |Manual Automated 18
Slide 21: The Solution (4 years in the making)
e Solution (4 years in the maki + Initial Application: High pressure digestion + Consumable: — Proprietary 8-well strips + Number of Samples: — 48 samples + User Control: — Easy to use touch screen LabView Software 19
Slide 22: Barozyme HT48: High Throughput PCT Processing
Barozyme HT48: High Throughput PCT Processing Planned Release - June 16, 2014
Slide 23: Initial (Jan 2015) Commercial Application: Barozyme HT48
Initial (Jan 2015) Commercial Application: Barozyme HT48 PBI Biomarker Discovery (Enhanced Mass Spectrometry Sample Preparation) We Believe: + there are approx 16,000 MS labs worldwide (8,000 U.S.); approx 50% do protein analysis + most MS protein analyses require extraction then digestion of protei
Slide 24: Initial (Jan 2016) Commercial Application: Barozyme HT48
Initial (Jan 2016) Commercial Application: Barozyme HT48 Forensics (Enhanced Rape Kit Sample Preparation) We Believe: there is a backlog of ~400,000 untested Rape Kits in the U.S. & ~ 300,000 new rapes/year + because of the high cost and complexity of rape kit testing, the backlog continues to grow
Slide 25: Key Investment Highlights
Key Investment Highlights PBI Pressure Cycling Technology (PCT): Powerful, Enabling, Patented with Significant Advantages Over Competitive Methods Proven Technology: ~ 250 Installations in ~150 Marquee Laboratories Attractive “Razor/Razorblade” Business Model Experienced Management Team and Board of
Pressure Biosciences — Investor Presentation (July 2014) on 6ix